1-17 of 17
A Guerci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience.

C. Kelaidi, S. Chevret, S. de Botton, E. Raffoux, A. Guerci, X. Thomas, C. Gardin, A. Pigneux, A. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, S. Meyer-Monard, R. Chelo, T. Pabst, P. Chevalier, F. Maloisel, E. Deconinck, A. Ferrant, D. Bron, N. Fegueux, J. de la Serna, G. Martin, J. Cahn, N. Ifrah, B. Cassinat, H. Dombret, M.A. Sanz, Pierre Fenaux, L. Ades
Journal: Blood
Blood (2007) 110 (11): 1845.
https://doi.org/10.1182/blood.V110.11.1845.1845
Published: 2007
Journal Articles

MDS with Isolated Neutropenia or Thrombocytopenia. Incidence and Characteristics in the Groupe Francophone des Myélodysplasies (GFM) Registry.

Sophie Park, MD, V. Andrieu, R. Sapena, G. Leroux, A. Stamatoullas, M.P. Callat, O. Beyne-Rauzy, J. Mairesse, M.P. Chaury, Herve Dombret, V. Siguret, Norbert Vey, G. Lepeu, A. Guerci, S. Cheze, Pierre Fenaux, F. Dreyfus
Journal: Blood
Blood (2007) 110 (11): 2456.
https://doi.org/10.1182/blood.V110.11.2456.2456
Published: 2007
Journal Articles

Bortezomib + Low Dose Cytarabine in Int-2 and High Risk MDS. Interim Results of a Phase I/II Trial by the GFM.

Shanti Natarajan, Pierre Fenaux, Norbert Vey, A. Guerci, I. Coulibaly, A. Charbonnier, C. Ravoet, S. Courby, G. Etienne, M.P. Chaury, S. Cheze, A. Stamatoullas, L. Legros, E. Berger, A. Lescoute, S. Vaultier, F. Dreyfus
Journal: Blood
Blood (2007) 110 (11): 1453.
https://doi.org/10.1182/blood.V110.11.1453.1453
Published: 2007
Journal Articles

Low Doses of Thalidomide (Thal) in Low Risk MDS with Transfusion-Dependant Anemia: The GFM THAL-SMD-200 Trial.

J. Tamburini, C. Elie, D. Vassilief, M.C. Quarre, O. Beyne-Rauzy, M. Gardembas, A. Aouba, C. Berthou, L. Sanhes, A. Guerci, A. Stamatoullas, F. Bauduer, J.J. Sotto, L. Legros, S. Vaultier, P. Fenaux, F. Dreyfus, D. Bouscary
Journal: Blood
Blood (2006) 108 (11): 2673.
https://doi.org/10.1182/blood.V108.11.2673.2673
Published: 2006
Journal Articles

Variant Philadelphia-Positive Chronic Myeloid Leukemia, der(9) Deletions and Response to Imatinib Mesylate: A Retrospective Multicentric Analysis from the French Fi-LMC Group.

S. Corm, MD, Franck Nicolini, S. Richebourg, F. Huguet, D. Rea, I. Tigaud, N. Dastugue, S. Raynaud, L. Legros, J. van den Akker, F.X. Mahon, F. Maloisel, C. Roche-Lestienne, A. Guerci, C. Preudhomme, V. Eclache
Journal: Blood
Blood (2006) 108 (11): 2113.
https://doi.org/10.1182/blood.V108.11.2113.2113
Published: 2006
Journal Articles

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results.

L. Ades, MD, M. Sanz, MD, S. Chevret, MD, S. De Botton, MD, G. Martin, MD, E. Raffoux, MD, E. Vellenga, MD, A. Guerci, MD, M. Gonzalez, MD, A. Pigneux, MD, C. Rayon, MD, A.M. Stoppa, MD, J. De la Serna, MD, T. Pabst, MD, S. Meyer-Monard, MD, R. Parodi, MD, J. Bergua, MD, F. Rigal-Huguet, MD, A. Vekhoff, MD, S. Negri, MD, N. Fegueux, MD, A. Ferrant, MD, D. Bron, MD, H. Dombret, MD, L. Degos, MD, P. Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 544.
https://doi.org/10.1182/blood.V106.11.544.544
Published: 2005
Journal Articles

Is There a Role for ATRA in Combination to EPO in Lower Risk Myelodysplastic Syndrome? Preliminary Results of a Phase II Study.

L. Ades, H. Mohamed, D. Vassilief, E. Berger, B. Slama, N. Vey, R. Delarue, O. Beyne-Rauzy, A. Guerci, S. Cheze, X. Thomas, A. Stamatoullas, M. Gardembas, F. Bauduer, A. Kolb, M.C. Chaury, L. Legros, G. Damaj, F. Hamza, S. Vaultier, F. Dreyfus, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 2537.
https://doi.org/10.1182/blood.V106.11.2537.2537
Published: 2005
Journal Articles

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

C. Kelaidi, L. Ades, S. Chevret, M. A. Sanz, A. Guerci, X. Thomas, S. de Botton, E. Raffoux, C. Rayon, J. de la Serna, A. Ferrant, D. Bron, H. Link, N. Fegueux, D. Bordessoule, F. Rigal-Huguet, A.M. Stoppa, A. Vekhoff, S. Meyer-Monard, M. Fey, S. Castaigne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 890.
https://doi.org/10.1182/blood.V106.11.890.890
Published: 2005
Journal Articles

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000).

L. Ades, E. Raffoux, S. Chevret, S. de Botton, A. Guerci, A. Pigneux, A.M. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, T. Pabst, S. Meyer-Monard, F. Maloisel, E. Deconinck, D. Caillot, N. Gratecos, J.J. Sotto, A. Ferrant, P. Turlure, X. Thomas, N. Fegueux, P. Brault, O. Reman, P. Chevallier, P. Travade, V. Leblond, G. Leverger, A. Stamatoullas, C. Pautas, B. Beve, C. Chomienne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2004) 104 (11): 391.
https://doi.org/10.1182/blood.V104.11.391.391
Published: 2004
Journal Articles

Thalidomide for the Treatment of Low Risk Myelodysplasia.

D. Bouscary, MD-PhD, M. C. Quarre, MD, D. Vassilief, MD, O. Beyne Rouzy, MD, A. Aouba, MD, C. Berthou, MD, C. Gardembas, MD, L. Sanhes, MD, A. Guerci, MD, B. Mahe, MD, A. Stamatoullas, MD, F. Bauduer, MD, J. J. Sotto, MD, L. Legros, MD-PhD, S. Vaultier, ARC, P. Fenaux, MD-PhD, F. Dreyfus, MD
Journal: Blood
Blood (2004) 104 (11): 1438.
https://doi.org/10.1182/blood.V104.11.1438.1438
Published: 2004
Journal Articles

Incidence, Clinical Features, and Outcome of All Trans -Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

S. De Botton, H. Dombret, M. Sanz, J. San Miguel, D. Caillot, R. Zittoun, M. Gardembas, A. Stamatoulas, E. Condé, A. Guerci, C. Gardin, K. Geiser, D. Cony Makhoul, O. Reman, J. de la Serna, F. Lefrere, C. Chomienne, C. Chastang, L. Degos, P. Fenaux, the European APL Group
Journal: Blood
Blood (1998) 92 (8): 2712–2718.
https://doi.org/10.1182/blood.V92.8.2712
Published: 1998
Journal Articles

A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group

E Wattel, A Guerci, B Hecquet, T Economopoulos, A Copplestone, B Mahe, ME Couteaux, L Resegotti, V Voglova, C Foussard, B Pegourie, JL Michaux, E Deconinck, AM Stoppa, G Mufti, D Oscier, P Fenaux
Journal: Blood
Blood (1996) 88 (7): 2480–2487.
https://doi.org/10.1182/blood.V88.7.2480.bloodjournal8872480
Published: 1996
Journal Articles

Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry

A Guerci, JL Merlin, N Missoum, L Feldmann, S Marchal, F Witz, C Rose, O Guerci
Journal: Blood
Blood (1995) 85 (8): 2147–2153.
https://doi.org/10.1182/blood.V85.8.2147.bloodjournal8582147
Published: 1995
Journal Articles

Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]

P Fenaux, E Wattel, E Archimbaud, M Sanz, B Hecquet, N Fegueux, A Guerci, H Link, M Fey, S Castaigne
Journal: Blood
Blood (1994) 84 (2): 666–667.
https://doi.org/10.1182/blood.V84.2.666.666
Published: 1994
Journal Articles

Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies

JL Merlin, A Guerci, S Marchal, N Missoum, C Ramacci, JC Humbert, T Tsuruo, O Guerci
Journal: Blood
Blood (1994) 84 (1): 262–269.
https://doi.org/10.1182/blood.V84.1.262.262
Published: 1994
Journal Articles

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

P Fenaux, MC Le Deley, S Castaigne, E Archimbaud, C Chomienne, H Link, A Guerci, M Duarte, MT Daniel, D Bowen
Journal: Blood
Blood (1993) 82 (11): 3241–3249.
https://doi.org/10.1182/blood.V82.11.3241.3241
Published: 1993
Journal Articles

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

P Fenaux, S Castaigne, H Dombret, E Archimbaud, M Duarte, P Morel, T Lamy, H Tilly, A Guerci, F Maloisel
Journal: Blood
Blood (1992) 80 (9): 2176–2181.
https://doi.org/10.1182/blood.V80.9.2176.2176
Published: 1992